[EBV infection revealing a long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency in a 3-year-old boy]

A Desbrée1, L Houdon, G Touati

  • 1Service de pédiatrie, CHU de Saint-Etienne, hôpital Nord, avenue Albert-Raimond, 42055 Saint-Etienne cedex 2, France. aureliedesbree@hotmail.com

Insights

Long-chain-3-hydroxyacyl-CoA-dehydrogenase (LCHAD) deficiency, a fatty acid metabolism disorder, can present late due to specific diets. Neonatal screening is crucial for affected newborns and at-risk pregnancies.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Long-chain-3-hydroxyacyl-CoA-dehydrogenase (LCHAD) deficiency is an autosomal recessive disorder impacting fatty acid metabolism.
  • Typically diagnosed before age two, LCHAD deficiency affects approximately 1-9 per 100,000 individuals.

Observation:

  • A 3-year-old child presented with hypoglycemic hypoketotic coma following Epstein-Barr virus (EBV) infection.
  • Genetic analysis revealed a G1528C homozygote mutation, confirming LCHAD deficiency.
  • The patient developed pigmentary retinopathy and increased muscle weakness after two years despite dietary management and L-carnitine supplementation.

Findings:

  • Late presentation of LCHAD deficiency in this case was linked to a diet low in animal fats and prolonged breastfeeding.
  • Heterozygous mothers carrying an affected fetus are at risk for HELLP or AFLP syndromes during the third trimester of pregnancy.

Implications:

  • This case highlights the importance of considering dietary factors in the presentation of metabolic disorders.
  • The findings support the implementation of systematic neonatal screening for LCHAD deficiency.
  • Specific monitoring protocols for newborns diagnosed with LCHAD deficiency and at-risk pregnancies are recommended to prevent severe maternal and fetal complications.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Lipid Catabolism01:25

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...